Resources | NeuroKaire (formerly GenetikaPlus)

Shiran Zimri, Nitai Kerem, Daphna Laifenfeld, David Pattison, Niva Russek-Blum, Diana Shtossel, Vered Sasson, Eidan Loushi, Natalya Yarovinsky, Rafi Hadad, Judith Aharon Peretz, Ferenc Tracik & Rachel Ben-Hayun. NeuroSense Therapeutics, Ltd, Herzliya, Israel | GenetikaPlus, Tel Aviv, Israel | Stroke and Cognition Institute, Rambam Health Care Campus, Haifa, Israel | Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Publications

November 8, 2023

NEI Congress 2023 Presentation: Using patient iPSC-derived neurons to uncover mechanisms associated with response to antidepressant drugs: a framework for precision medicine in depression*

Aleksandra Kugel, PhD, Dana Maimon, MSc, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

Publications

September 6, 2023

Psych Congress 2023 Presentation: Precision Medicine in Depression: Response to Antidepressants is Associated with the Interplay Between Genetic Variants and Gene Expression Levels in Patient-Derived Neurons

Aleksandra Kugel, PhD, Dana Maimon, MSc, Shahar Shohat Koren, PhD, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

Publications

May 20, 2023

APA 2023 Presentation: Elevated COMT expression in depressed patient derived neurons is associated with a higher response rate to SSRIs and lower response rate to bupropion

Shahar Shohat Koren, PhD, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

Publications

July 22, 2022

Genetika+: precision medicine solutions for mental health

Claudia Albeldas, Niv Cohen, Sari Natan, Nadav Askari, Daphna Laifenfeld & Talia Cohen Solal

Publications

April 1, 2021

Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response

Yishai Avior, Shiri Ron, Dana Kroitorou, Claudia Albeldas, Vitaly Lerner, Barbara Corneo, Erez Nitzan, Daphna Laifenfeld & Talia Cohen Solal

Dr. Talia Cohen Solal, CEO of NeuroKaire

The Mental Health of Olympians: Coping with Pressure and Expectations

David Pattison, Head of Business Development

Managing Election Stress: Five Ways to Protect Your Mental Health

No Results Found.

We're sorry, but no results matched your search criteria. Please consider modifying your filters or search parameters and try again.

NeuroSense and NeuroKaire (formerly Genetika+) Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease

NeuroKaire (formerly Genetika+): Transforming Digital Health with Precision Medicine Innovations

Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare

How artificial intelligence is matching drugs to patients

Treatment Approach to Depression Sees Paradigm Shift

Clexio and NeuroKaire (formerly Genetika+) Announce Partnership Using Proprietary Antidepressant Screening Platform

Science seeks new ways to tackle depression: early detection of risks and personalized treatment

Defeating depression through early risk detection and targeted medication

Extreme Tech Startup Spotlight: Genetika+

How Brain-in-a-Dish Technology Can Impact the Treatment of MDD

NeuroKaire (formerly Genetika+) Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment

'Brain-In-A-Dish' Helps Patients Find The Right Antidepressant

KSM Research & Innovation And NeuroKaire (formerly Genetika+) Partner To Seek AI Solutions For Personalization Of Depression Treatment

TheMarker Names NeuroKaire (formerly Genetika+) One of the Top 20 Startups

NeuroKaire (formerly Genetika+) Publication Featured in Future Medicine

NeuroKaire (formerly Genetika+) awarded up to €17.5M from European Commission's European Innovation Council (EIC) Accelerator for Europe’s high potential start-ups

Dr. Daphna Laifenfeld Speaks at PMWC 2022

ScienceAbroad hosts Dr. Daphna Laifenfeld at Google Campus

NeuroKaire (formerly Genetika+) Wins the BioNJ BioPartnering Company & Pitch Presentation MedTech Award at the BioNJ 12th Annual Bio Partnering Conference

CTO, Nadav Askari, Presents at Biomed Israel

Female Led NeuroKaire (formerly Genetika+) Grew and Gained Funding Through MassChallenge

NeuroKaire's (formerly Genetika+) CEO Talia Cohen Solal Brings Precision Medicine to Brain Health

NeuroKaire (formerly Genetika+), Pioneer in Personalized Medicine for Psychiatry, Raises $10 Million in an Oversubscribed Series A

Psych Congress 2024

APA Annual Meeting 2024

PMWC 2024

CNS Summit 2023

Psych Congress 2023

APA Annual Meeting 2023

Biomed Israel 2023

Translational neuroscience session hosted by Bina - Bridge Innovate Nurture Advance

Pharma 2023 (Reuters Events)

Israeli Society for Biological Psychiatry

EPA 2023

AD/PD 2024 Presentation: Combination Of Ciprofloxacin/Celecoxib As A Novel Therapeutic Approach For Alzheimer’s Disease

NEI Congress 2023 Presentation: Using patient iPSC-derived neurons to uncover mechanisms associated with response to antidepressant drugs: a framework for precision medicine in depression*

Psych Congress 2023 Presentation: Precision Medicine in Depression: Response to Antidepressants is Associated with the Interplay Between Genetic Variants and Gene Expression Levels in Patient-Derived Neurons

APA 2023 Presentation: Elevated COMT expression in depressed patient derived neurons is associated with a higher response rate to SSRIs and lower response rate to bupropion

Genetika+: precision medicine solutions for mental health

Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response

The Mental Health of Olympians: Coping with Pressure and Expectations

Managing Election Stress: Five Ways to Protect Your Mental Health

Contact Us